A systematic framework and software are needed to implement material traceability in continuous pharmaceutical tablet manufacturing. Pharmaceutical manufacturing is an area with strict regulations ...
Information on significant properties of pharmaceutical tablets, such as their mechanical strength and dissolution, can now be obtained without resorting to the conventional, time-consuming and ...
Maximizing physical-chemical identifiers: Colorcon and ARmark's visual and covert film-coating technologies The regulatory landscape for improving anticounterfeiting technologies has greatly improved ...
SCHAUMBURG, Ill.--(BUSINESS WIRE)-- Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that APP Pharmaceuticals will immediately begin marketing Letrozole Tablets in the U.S., after the U.S ...
Mumbai, November 5, 2008: Sun Pharmaceutical Industries Ltd. (Reuters:SUN.BO, Bloomberg:SUNP IN, NSE:SUNPHARMA, BSE:524715) announced that USFDA has granted approval for the Abbreviated New Drug ...
ANI Pharmaceuticals, Inc. announced the launch of its Prucalopride Tablets, a generic version of the drug Motegrity®, following final FDA approval of their Abbreviated New Drug Application. The new ...
The global Pharmaceutical Dissolution Testing Services Market is anticipated to reach US$ 693.12 Million in 2023 and US$ 1,538.48 Million by 2033, with a CAGR of 8.3% from 2023 to 2033. The expansion ...
ADALAT ® XL ® (nifedipine extended-release tablets) first received market authorization in Canada in 1995 and is indicated for the management of chronic stable angina and the management of mild to ...
Daewoong Pharmaceutical said on the 27th that it has launched Zeltopa tablets, a JAK inhibitor–class treatment for autoimmune diseases. JAK inhibitors are drugs widely used to treat autoimmune ...
Baltimore, Maryland, Lupin Pharmaceuticals Inc. announced today that it has voluntarily recalled lot L600518, Exp 05/18 of Mibelas 24 Fe (Norethindrone Acetate and Ethinyl Estradiol 1 mg/0.02 mg ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results